Hunter James R相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral naïve Brazilian people with HIV

一项针对近期确诊的未接受过抗逆转录病毒治疗的巴西HIV感染者，开展的全国横断面分析，旨在监测其耐药突变情况。

期刊:Lancet Regional Health-Americas

影响因子:7.6

doi:10.1016/j.lana.2025.101283

Caldeira, Debora Bellini; Constant Vergara, Tania Regina; Schechter, Mauro; Bicudo, Eliana Lima; Freitas Lopes, Carmen Andréa; Brites, Carlos; Sprinz, Eduardo; Fernandes, Juliana Corvo; Silveira, Orival Silva; Durães-Carvalho, Ricardo; Galinskas, Juliana; Treitsman, Mauro Sérgio; Gomes de Sousa, Marcos Davi; de Figueiredo Fernandes, Márcio; Helfer, Mateus Swarovsky; Grilo, Ney Almeida; Caseiro, Marcos Montani; Sanz Duro, Rodrigo Lopes; Bassini, Alessandra Simões; Hunter, James R; Janini, Luiz Mário; Diaz, Ricardo Sobhie

发表日期：2025

文献求助收藏

Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV

联合治疗干预和树突状细胞疗法对 HIV 感染者病毒学和免疫学结果的影响

期刊:Journal of Infectious Diseases

doi:10.1093/infdis/jiaf430

Ndhlovu, Lishomwa C; Giron, Leila B; Galinskas, Juliana; Premeaux, Thomas A; Pang, Alina P S; Dias, Danilo; de Almeida Baptista, Marcella Vassão; Shytaj, Iart Luca; Maricato, Juliana T; Ferreira, Paulo R A; Gosuen, Gisele; Corley, Michael J; Friday, Courtney M; Bowler, Scott A; Della Libera, Ermelindo; Sucupira, Maria Cecilia; Hunter, James R; Janini, Luis Mário; Schechter, Mauro; Savarino, Andrea; Diaz, Ricardo Sobhie

树突状细胞

细胞生物学

树突状细胞

免疫/内分泌

发表日期：2025

文献求助收藏

T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess

T细胞介导的免疫反应及其炎症相关因素与COVID-19临床严重程度的关系：并非凭直觉猜测

期刊:BMC Infectious Diseases

doi:10.1186/s12879-024-09490-y

Pena, Nathalia Mantovani; Santana, Luiz Claudio; Hunter, James R; Blum, Vinicius Fontanesi; Vergara, Tania; Gouvea, Celso; Leal, Elcio; Bellei, Nancy; Schechter, Mauro; Diaz, Ricardo Sobhie

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil

巴西一线治疗失败后多替拉韦相关耐药突变

期刊:BMC Infectious Diseases

doi:10.1186/s12879-023-08288-8

Diaz, Ricardo Sobhie; Hunter, James R; Camargo, Michelle; Dias, Danilo; Galinskas, Juliana; Nassar, Isabela; de Lima, Isaac Barbosa; Caldeira, Debora Bellini; Sucupira, Maria Cecilia; Schechter, Mauro

发表日期：2023

文献求助收藏

Could well-established, widely available, and simple laboratory techniques explain a laboratory origin of SARS-CoV-2?

成熟、普及且简单的实验室技术能否解释 SARS-CoV-2 的实验室起源？

期刊:Brazilian Journal of Infectious Diseases

影响因子:2.8

doi:10.1016/j.bjid.2023.102808

Lloyd, Robert M Jr; Hunter, James R; Diaz, Ricardo Sobhie; Schechter, Mauro

发表日期：2023

文献求助收藏

Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16

有效的噬菌体混合物可对抗日益增多的广泛耐药性肺炎克雷伯菌16型序列。

期刊:Emerging Microbes & Infections

影响因子:7.5

doi:10.1080/22221751.2022.2051752

Martins, Willames M B S; Li, Mei; Sands, Kirsty; Lenzi, Michael H; Portal, Edward; Mathias, Jordan; Dantas, Priscila P; Migliavacca, Roberta; Hunter, James R; Medeiros, Eduardo A; Gales, Ana C; Toleman, Mark A

发表日期：2022

文献求助收藏

Corrigendum to "Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial." [EClinicalMedicine 37 (2021) 100981]

对“尼他唑尼治疗中度 COVID-19 优于安慰剂——一项概念验证性随机双盲临床试验”的更正。[EClinicalMedicine 37 (2021) 100981]

期刊:EClinicalMedicine

影响因子:10

doi:10.1016/j.eclinm.2021.101203

Blum, Vinicius Fontanesi; Cimerman, Sérgio; Hunter, James R; Tierno, Paulo; Lacerda, Acioly; Soeiro, Alexandre; Cardoso, Florentino; Bellei, Nancy Cristina; Maricato, Juliana; Mantovani, Nathalia; Vassao, Marcella; Dias, Danilo; Galinskas, Juliana; Janini, Luis Mário Ramos; Santos-Oliveira, Joanna Reis; Da-Cruz, Alda Maria; Diaz, Ricardo Sobhie

发表日期：2021

文献求助收藏

Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.

尼他唑尼治疗中度 COVID-19 优于安慰剂 - 一项概念验证性随机双盲临床试验

期刊:EClinicalMedicine

影响因子:10

doi:10.1016/j.eclinm.2021.100981

Blum Vinicius Fontanesi, Cimerman SÃ©rgio, Hunter James R, Tierno Paulo, Lacerda Acioly, Soeiro Alexandre, Cardoso Florentino, Bellei Nancy Cristina, Maricato Juliana, Mantovani Nathalia, Vassao Marcella, Dias Danilo, Galinskas Juliana, Janini Luis MÃ¡rio Ramos, Santos-Oliveira Joanna Reis, Da-Cruz Alda Maria, Diaz Ricardo Sobhie

发表日期：2021

文献求助收藏